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A B S T R A C T
Aim of the study was to estimate the in-hospital mortality and death rate in patients with AMI according to gender and
location of infarction during 5 years before and after the introduction of percutaneous coronary intervention (PCI) proce-
dures in Split University Hosptial Center, Croatia. The hospitalized patients were devided in two groups, from 2000 to 2004
and from 2005 to 2009. The analysis included total mortality and mortality according to gender and location of AMI. The
location of infarction was detected toward typical ECG changes. The analysis included the model of death in patients with
AMI and in-hospital mortality of patients undergoing the PCI procedures. The patients in the first group were treated with
the standard medication therapy, and the patients in the second group were treated with PCI. The number of hospitalized
patients with AMI, in ten years, increased from 475 to 652. A total of 5339 patients with AMI were hospitalized, and
included 67.5% males and 32.5% females. The first group included 2336 patients (68% males and 32% females). The
second group included 2973 patients (67% males and 33% females). Male patients in average were 5 years younger than
female patients. A total in-hospital mortality was significantly higher in the first group (13.5 vs. 7.6%). The mortality in the
first group was significantly higher in females (22.7 vs. 12%) and in males (9 vs. 5.5%) comparing with second group.
In-hospital mortality in the patients with STEMI was significantly higher in the first group (16.6 vs. 9%). Among the
patients with NSTEMI there were no significantly differences in the in-hospital mortality (4 vs. 2.5%). The most frequent
trigger of death in males were ventricular fibrillation in both groups such as heart failure in females. Cx occlusion is more
often among the male patients treated with PCI. In-hospital mortality in patients with STEMI treated with PCI was 5.7%.
A in-hospital mortality in the patients with AIM after PCI was almost halved. Females had two times higher in-hospital
mortality before and after PCI introduction.
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Introduction
Myocardial infarction is probably the most important
manifestation of atherosclerosis. It occurs as a conse-
quence of long term development of atherosclerotic chan-
ges in coronary vessels caused by various risk factors as
hypertension, hypercholesterolemia, smoking diabetes,
stress, obesity, heredity and eldery1–4. The pathological
basis of acute myocardial infarction with ST elevation
(STEMI) is usually based on rupture of unstable athe-
rosclerotic plaque and the following thrombotic occlusion
of coronary vessel with consequential necrosis of heart
muscle followed by increase of corresponding enzyme
values. Rupture of unstable plaque and thrombotic occlu-
sion in myocardial infarction without ST elevation (NS-
TEMI) is followed by delayed recanalization of coronary
vessel. Delay of recanalization also causes necrosis of
myocardial muscle and increase of enzymes. Early recog-
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nition of acute myocardial infarction and urgent trans-
port to coronary care unit reduce damage of heart muscle
and rate of death5–7.
More than 50% of total mortality in developed coun-
tries, as well as in Croatia, belong to cardiovascular dis-
ease, and 50% of deaths are because of coronary diseases.
According to that, every fourth or fifth patient die be-
cause of myocardial infarction8.
In the last 30 years, in-hospital mortality because of
acute myocardial infarction (AMI), decreased from 25–
30% to 7–10% in North America and West Europe. This
decreasing in mortality is due to introduction of Coro-
nary Care Units, new medications suchas beta-blockers
and fibrinolytics, and introduction of percutaneous coro-
nary interventions (PCI)9.
In Croatian capital Zagreb mortality of AMI was 50%
from 1979 to 2001, and 31% of the AMI patients die out
of hospital10. In Split, the second biggest city in Croatia,
in 2002 diagnosis of AMI was established in 1022 pa-
tients, among them only 450 (44%) were hospitalized. A
total 30-day mortality of AMI was 30–50%, and half of
the AMI patients died in the first two hours11,12. PCI was
introduced in University Hospital Split (UHS) in 2005,
with 24-hour intervention team available for invasive
treatment of AMI. The goal of this study was to analyze a
total in-hospital mortality of patients with AMI, accord-
ing to infarction location and gender, 5 years before and
after PCI introduction.
Methods of Analysis
This was a prospective study of patients hospitalized
with AMI in UHS, from January 2000 to December 2009.
The following data were collected from the patients’
charts: date of hospital admission, age, gender, location
of AMI, therapy administered in the hospital (ASK, be-
ta-blockers, ACE inhibitors, fibrinolytics and PCI after it
had been introduced), in-hospital patient outcome (sur-
vived/died), mechanism of death (according to ECG chan-
ges and clinical evaluation) and mortality according to
age and gender in AMI patients undergoing PCI treat-
ment. For comparison of in-hospital mortality, patients
were divided into two groups – patients treated before
PCI was introduced (January 2000 – December 2004)
and patients treated after the PCI introduction (January
2005 – December 2009).
Inclusion criteria were clinical signs and symptoms of
myocardial infarction, ECG changes and enzyme values
in blood analysis.
Location of myocardial infarction was determined ac-
cording to ECG changes.
ST elevation more than 1 mm from V1 to V4 and
growing troponin were denoted as anteroseptal ST-seg-
ment elevation myocardial infarction (STEMI), ST eleva-
tion in II, III and aVF as inferior STEMI, and ST eleva-
tion in I, aVL, V5 and V6 as lateral STEMI. ST denive-
lation more than 1 mm and T wave inversion with grow-
ing value of troponin were denoted as non-ST-segment
elevation myocardial infarction (NSTEMI) infarction.
The patient data were anonymized and recorded in
electronic charts. Categorical data were presented as
frequencies and percents. The statistical analysis of data
was performed with statistical package GrapPad Prism
(GraphPad Inc, San Diego, CA, USA) using chi-squared
(c2) test. Statistical significance level was set as p<0.05.
Continuous variables were expressed as means and stan-
dard deviation (X±SD).
Results
In the period from 2000 to 2009, 5339 patients wih
AMI were hospitalized in UHS – 3600 (67%) men aged
61.1±9.7 and 1739 (33%) women aged 66.3±10.4 years.
Before PCI introduction (years 2000 to 2004), 2366 AMI
patients were treated, 1608 (68%) men aged 61.2±9.6
years and 758 (32%) women aged 66.4±10.5 years. After
the PCI introduction (years 2005 to 2009), 2973 patients
were included, 1992 (67%) men aged 61.0±9.4 years and
981 (33%) women aged 66.2±10.2 years. These results
demonstrate that the average age of men and women in




























































Fig. 1. Number of hospitalized patients with myocardial infarction and in-hospital mortality in University Hospital Split according to
years from 2000 to 2009.
the both periods remained unchanged, with women be-
ing on average 5 years older. The number of patients hos-
pitalized for AMI in UHS grew from 475 in 2000 to 652 in
2009.
Average in-hospital mortality before PCI introduction
was 13.5%, and after the PCI introduction it decreased to
7.6% (c²=49.71; p<0.01) (Figure 1). The in-hospital
mortality rates were reduced after introduction of PCI
both in men (9.0 vs. 5.5%; c²=37,1; p<0.01), and in
women (23 vs. 12%; c²=24.5; p<0.01).
During the two observed periods, the number of pa-
tients with STEMI of anterior and inferior location was
almost equal (26–29%), representation of STEMI of lat-
eral location was significantly lower (14–15%), and the
percentages of NSTEMI infarction was higher (21–23%)
(p<0.05). The myocardial infarction without clear loca-
tion included 6–8% patients (usually patients with left
bundle branch block and idioventricular rhythm in ter-
minal stage).
In-hospital mortality before PCI introduction was
higher in patients with STEMI of anteroseptal location
(20%), compared with period after PCI introduction (11%).
Patients with STEMI of inferior and lateral location, in
the same period, had lower in-hospital mortality (15%),
compared with period after PCI introduction (8%). The
lowest in-hospital mortality was recorded in the group of
patients with NSTEMI 4%.
After the PCI was introduced (from 2005 to 2009), to-
tal in-hospital mortality was 50% lower, as well as mor-
tality according to AMI location, comparing to pre-PCI
period (Figure 3).
The main cause of death in men was ventricular
fibrillation in both analyzed periods, but the frequency of
ventricular fibrillation increased from 47% before PCI to
59% after the PCI introduction. Heart failure was the
most common cause of death in women both before
(38%) and after (49%) the PCI introduction (Figures 4
and 5). Ventricular fibrillation was significantly more
common cause of death in men comparing to women
both before the PCI (47 vs. 20%; c²=26.7, p<0.001) and
after the PCI introduction (59 vs. 20%; c²=38, p<0.001).
Heart failure was significantly more frequent cause of
death in women comparing to men before PCI (38 vs.
20%; c²=13.4, p<0.001) and after PCI introduction (49%
vs. 25%; c²=14.62 p<0.001). In both periods cardiogenic
shock and myocardial rupture as causes of death were
more frequently observed in women than in men, and
after introduction of PCI frequency of both these causes
of death was reduced in women and men (Figures 4 and
5).
In-hospital mortality among the patients with STEMI
was 17% before PCI introduction and 9% after the PCI
introduction (c²=37.9; p<0.01). Among patients with
NSTEMI there were no significantly differences in the
in-hospital mortality in the period before and after PCI
(4 vs. 2.5%; c²=2.1; p=0.15).





















































Total: 2366 Number of deaths:
319 (13,5%)
Fig. 2. Representation of location of myocardial infarction and
























































Total: 2973 Number of deaths:
226 (7,6%)
Fig. 3. Representation of location of myocardial infarction and



















































Fig. 4. Mechanism of dying in patients with myocardial infarc-
tion in males and females in Split University Hospital Center


















































Fig. 5. Mechanism of dying in patients with myocardial infarc-
tion in males and females in Split University Hospital Center
from 2005 do 2009.
Analysis of patients with STEMI undergoing PCI
procedures in the period from 2005 to 2009, demonstrat-
ed that men were mostly in the age group between 40 to
60 years, and women between 60 and 90 years. Analysis
of coronary artery occlusion in patients treated with PCI
showed that occlusion of circumflex artery was signifi-
cantly more frequent in men than in women (20 vs. 10%;
c²=7.2; p<0.01).
Among 638 AMI patients who had died in-hospital
during 2005–2009 period, there were 481 (76%) men and
156 (24%) women. In-hospital mortality of women with
STEMI who were treated with PCI was almost 2.5 times
higher comparing to men (10% vs. 4.2%; c²=7.82, p<
0.01).
Discussion and Conclusion
After the introduction of percutaneous coronary in-
tervention, the in-hospital mortality of patients with
acute myocardial infarction at Split University Hospital
Center was decreased by 44%. In the analyzed ten-year
period (2000–2009), the annual in-hospital mortality was
reduced from 14% in 2000 to 4% in year 2009. At the
same time, the number of patients hospitalized due to
AMI at UHS increased by 28% in the year 2009, compar-
ing to year 2000.
The incidence of myocardial infarction in Croatia in
the last decade slowely decreased, whereas number of hos-
pitalisation because of AMI (in both gender) increased12.
In the last century (analysed period from 1970 to 1990),
coronary artery disease (CAD) mortality rate in Croatia,
was lower than in the developed countries. The developed
European countries work on successful preventive mea-
sures and treatments and this is a cause of decreased CHD
mortality to 100 deaths on 100000 inhabitants.
In Croatia, in 1991, 150 deaths (because of CHD) on
100000 inhabitants where recorded, what is higher than
in developed countries, but lower than in Easten Euro-
pean countries, where mortality rate of CHD was 200–
270 on 100000 inhabitants13. The same trend was ob-
served in year 200014.
In our study, distribution of myocardial infarction ac-
cording to location was almost equal in the analyzed peri-
ods before and after introduction of PCI.
Distribution of myocardial infarction toward location
was in accordance to frequency of atherosclerotic les-
sions on coronary arteries. According to the available
data from the literature, the most frequent atheroscle-
rotic changes was on left anterior descending coronary
artery – 43.4%, than right coronary artery – 28.4% and
circumflex artery – 23.7%. This changes are in accor-
dance to haemodynamic load15.
Anteroseptal myocardial infarction developed after
occlusion of left anterior descending coronary artery, and
inferior infarction after occlusion of right or dominate
circumflex coronary artery, whereas lateral myocardian
infarction developed after occlusion of circumflex coro-
nary artery16.
Before introduction of PCI (period from 2000 to 2004),
a total in-hospital mortality of AMI patients was 13.5%.
The highest mortality was seen in patients with antero-
septal location of STEMI (20%). In-hospital mortality of
patients with STEMI of inferior and lateral location was
significantly lower (15%), as well as in the patients with
NSTEMI (4%). Mortality was often in correlation to size
of irrigation domain of coronary artery occlusion.
After the introduction of PCI (from 2005 to 2009),
in-hospital mortality of AMI patients was almost halved
(to 7.6%) as well as in-hospital mortality according to lo-
cation of myocardial infarction. This was the most im-
portant reason that in-hospital mortality of AMI in Uni-
versity Hospital Split in year 2009 became almost equal
to the results of developed European countries14.
The analysis of in-hospital mortality according to gen-
der before PCI introduction established that mortality of
women was almost 2.5 higher than in the men (22.7 vs.
9%). After the PCI intervention mortality in both women
and men decreased about 50%, but the mortality of
women was still more than twice higher than in men (12
vs. 5.5%). The higher mortality of AIM in women and fe-
male gender as a independent predictor of AIM mortality,
were proven in many studies17,18. In patients with AIM,
in-hospital mortality of women (after adjusting to age
and risk factors) was twice higher then mortality in
men19,20.
On the other hand, lot of authors, fortified that (after
adjusting to age), higher mortality in females become
equall to mortaliy in males21–23.
In our study, women with AIM were on average 5
years older than men, but after adjusting to other fac-
tors, in-hospital mortality of women was higher than in
males.
We found that men with AMI most commonly die be-
cause of ventricular fibrillation, and women because of
heart failure, cardiogenic shock and myocardial rupture.
After the introduction of PCI, the percent of men and
women dying from ventricular fibrillation and heart fail-
ure, respectively, increased, while mortality due to car-
diogenic shock and myocardial rupture decreased24.
It has already been described that women with AIM
at hospital admission, present more often with lung
rales, lung edemas and cardiogenic shock. Values of crea-
tin kinase and incidence of anterior location of AMI, in
both gender, had no statisticaly differences26. The au-
thors concluded that higher percentage of heart failure
in AMI of equal size, suggested that females in non-in-
farction myocardial regions had lower compensatory re-
serve, which makes congestion a more frequent problem
in women than in men26,27. Men are able to increase
heart volume with increasing of ejection fraction, and
women with increasing of end-diastolic volume. Echo-
cardiography investigation established that myocardial
mass is about 30% lower in women than in men, and ex-
planation for this could be effect of androgens25–27.
Authors, in different investigations, suggested that
men with AIM are more often dying because of malig-
D. Miri} et al.: In-Hospital Mortality of Acute Myocardial Infarction, Coll. Antropol. 37 (2013) 1: 207–212
210
nant arrhytmias, and women because of refractory de-
compensation, cardiogenic shock and myocardial ruptu-
re21–23.
This differences in cause of death between men and
women, could have explanation in gender differences, in
sensibility on ishaemic and reperfusion lessions, ele-
ctrophysiology specificity and differences in autonomic
regulations28,29. Activity of autonomic system have sig-
nificant role in prognosis of patients with acute coronary
syndrome. Hyperactivity of sympatic system could be
trigger of malignant arrhytmias, on the other side, activ-
ity of vagus could have antifibrillation effect29. Men more
often die in acute phases of myocardial infaction, with
higher sympatico-tonus and higher values of adrenaline
(in relation to pain and fear)21–23.
During two-minute occlusion of coronary arteries with
balloon in women, high vagus activity is associated with
bradicardia, decrease of blood pressure, and lower heart
ectopic activity. This vagus activity protects women of
malignant arrhytmias29,30.
This could be explanation of higher mortality in men
before hospitalization and higher in-hospital mortality in
acute myocardial infarction phases, while mortality in
women is significantly higher in subacute phases with
mechanical heart failure because of lower mass and
power of myocardium in females26,27.
Analysis of patients who underwent PCI interven-
tions according to gender demonstrated that the most
common age of treated men was between 40 and 60
years, while women were mostly between 60 and 90
years. Among patients with STEMI treated with PCI, the
most frequent coronary occlusions were detected at left
anterior descending coronary artery and right coronary
artery, in both genders. PCI procedures on circumflex ar-
teries were two time higher in men than in women. This
could be due to the higher hemodynamic burden of cir-
cumflex artery and stronger heart muscle in men, which
is in relation with higher risk of atherosclerotic lessions.
In-hospital mortality of patients with STEMI was
16% before and 9% after the introduction of STEMI. We
did not detect significant differences of in-hospital mor-
tality in patients with NSTEMI before and after intro-
duction of PCI procedures. NSTEMI patients were ini-
tially treated with standard treatment, and afterwards
they may have been treated with PCI procedures with
stent implantantion in subacute phases of myocardial in-
farction because of re-infarction prevention.
Analysis of in-hospital mortality of patients with myo-
cardial infarction treated with PCI demonstrated that to-
tal mortality was 5.7%; mortality of women was 2.5 times
higher than in men (10 vs 4.2%)31.
Women have lower possibility for myocardial infarc-
tion incident in fertility period because of estrogen role.
In menopause, when protective role of estrogen decrea-
ses, frequency of myocardial infarction in women ri-
ses21–23. We could conclude that women have lower inci-
dence of myocardial infarction, but after the incident,
mortality is significant higher.
According to our results, one third of patients with
STEMI were treated with PCI in acute phases, and
nearly 85% of patients with NSTEMI in subacute phases.
In-hospital mortality of patients with AMI treated with
standard therapy and PCI was 7.6%, mortality in pa-
tients with STEMI treated with PCI was 5.7%, and total
mortality of patients with myocardial infarction was 4%
in 2009.
These data are almost comparabile with the most de-
veloped European countries, where 40% of patients with
STEMI undergoing PCI procedures in clinical hospitals.
In conclusion, these data demonstrate that the intro-
duction of PCI was beneficial for AMI patients in Split,
Croatia. Even though the number of patients with AMI
in the analyzed ten-year period had increased, their aver-
age in-hospital mortality was reduced by 44% after the
introduction of PCI. As a result, treatment of acute myo-
cardial infarction in Split University Hospital Center is
now comparable to the most developed cardiology cen-
tres.
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BOLNI^KA SMRTNOST U BOLESNIKA S AKUTNIM INFARKTOM MIOKARDA PRIJE
I NAKON UVO\ENJA PERKUTANE KORONARNE INTERVENCIJE U KBC SPLIT, HRVATSKA
S A @ E T A K
Cilj rada je bio utvrditi bolni~ki mortalitet kod pacijenata s akutnim infarktom miokarda s obzirom na spol i loka-
lizaciju infarkta kroz 5 godina, prije i nakon uvo|enja perkutane koronarne intervencije u Klini~kom bolni~kom centru
Split. Hospitalizirani bolesnici su podijeljeni u dvije skupine, prva obuhva}a pacijente s akutnim infarktom miokarda
primljenih u bolnicu u razdoblju od 2000. do 2004. godine, a druga od 2005. do 2009. godine. Istra`ivanje uklju~uje
ukupnu smrtnost i smrtnost s obirom na spol i lokalizaciju infarkta miokarda. Lokalizacija je odre|ivana na temelju
tipi~nih EKG promjena. U analizu je uklju~en i na~in umiranja pacijenata s akutnim infarktom miokarda i onih kod
kojih je primijenjena perkutana koronarna intervencija. Pacijenti u prvoj skupini su lije~eni standardnom terapijom, a
oni u drugoj skupini, pored toga, i perkutanom koronarnom intervencijom. Ukupan godi{nji broj hospitaliziranih
bolesnika s akutnim infarktom miokarda, kroz period od 10 godina, pove}ao se od 475 na 652 bolesnika. Od ukupno
5339 hospitaliziranih bolesnika s akutnim infarktom miokarda 67,5% su bili mu{karci, a 32,5% su bile `ene. Prva grupa
je uklju~ivala 2336 bolesnika (68% mu{karaca i 32% `ena), a druga grupa je uklju~ivala 2973 bolesnika (67% mu{karaca
i 33% `ena). Mu{karci su bili u prosjeku 5 godina mla|i od `ena. Ukupni bolni~ki mortalitet je bio statisti~ki zna~ajno
ve}i u prvoj skupini (13,5 prema 7,6%). Mortalitet u prvoj skupini je bio statisti~ki zna~ajno ve}i u `ena (22,7 prema
12%) i u mu{karaca (9 prema 5.5%) u odnosu na drugu skupinu. Bolni~ki mortalitet u bolesnika s STEMI je bio zna-
~ajno ve}i u prvoj skupini (16,6 prema 9%). U bolesnika s NSTEMI nije bilo zna~ajne razlike u bolni~kom mortalitetu
izme|u skupina (4 prema 2,5%). Naj~e{}i uzrok smrti kod mu{karaca je bila ventrikularna fibrilacija u obje skupine dok
je u `ena to bilo popu{tanje srca. Okluzija cirkumfleksne koronarne arterije je bila ~e{}a u mu{karaca podvrgnutih
perkutanoj koronarnoj intervenciji. Bolni~ki mortalitet u bolesnika s STEMI lije~enih perkutanom koronarnom inter-
vencijom je bio 5,7%. Bolni~ki mortalitet u bolesnika s akutnim infarktom miokarda nakon primjene perkutane ko-
ronarne intervencije je bio skoro dvostruko umanjen. @ene su imale dvostruko vi{u bolni~ku smrtnost u razdoblju prije
i nakon uvo|enja perkutane koronarne intervencije.
D. Miri} et al.: In-Hospital Mortality of Acute Myocardial Infarction, Coll. Antropol. 37 (2013) 1: 207–212
212
